Steven Boland - Acrow MD CEO
ACF Stock | 1.08 0.01 0.92% |
CEO
Steven Boland is MD CEO of Acrow Limited
Address | 2A Mavis Street, Revesby, NSW, Australia, 2212 |
Phone | 61 2 9780 6500 |
Web | https://www.acrow.com.au |
Acrow Management Efficiency
The company has return on total asset (ROA) of 0.0804 % which means that it generated a profit of $0.0804 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.208 %, meaning that it generated $0.208 on every $100 dollars invested by stockholders. Acrow's management efficiency ratios could be used to measure how well Acrow manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Acrow's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 112.8 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 122 K in 2024.Similar Executives
Found 3 records | CEO Age | ||
Andrew BSc | Predictive Discovery | 59 | |
Cynthia Scott | Zip Co Limited | N/A | |
Paul Savich | WA1 Resources | N/A |
Management Performance
Return On Equity | 0.21 | ||||
Return On Asset | 0.0804 |
Acrow Limited Leadership Team
Elected by the shareholders, the Acrow's board of directors comprises two types of representatives: Acrow inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acrow. The board's role is to monitor Acrow's management team and ensure that shareholders' interests are well served. Acrow's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acrow's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Crowther, Group CFO | ||
Robert Parovel, Head Culture | ||
Shelby Coleman, Joint Secretary | ||
Jeffery Stewart, General Marketing | ||
CA BEC, Group Officer | ||
Steven Boland, MD CEO | ||
Max Crowley, Joint Secretary | ||
CPENG BE, Chief Officer | ||
Carl BCom, National Procurement | ||
Matthew Caporella, Chief Officer | ||
Carl Roetger, National Procurement | ||
Lee BA, Company Secretary |
Acrow Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acrow a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.21 | ||||
Return On Asset | 0.0804 | ||||
Profit Margin | 0.13 % | ||||
Operating Margin | 0.18 % | ||||
Current Valuation | 430.35 M | ||||
Shares Outstanding | 304.86 M | ||||
Shares Owned By Insiders | 21.02 % | ||||
Shares Owned By Institutions | 16.63 % | ||||
Price To Book | 2.34 X | ||||
Price To Sales | 1.72 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acrow Stock Analysis
When running Acrow's price analysis, check to measure Acrow's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrow is operating at the current time. Most of Acrow's value examination focuses on studying past and present price action to predict the probability of Acrow's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrow's price. Additionally, you may evaluate how the addition of Acrow to your portfolios can decrease your overall portfolio volatility.